Search Login Register

Exosurf (Exosurf Neonatal) Summary

Description: protein-free, synthetic surfactant containing dipalmitoylphosphatidylcholine, hexadecanol & tyloxapol; used in treatment of respiratory distress syndrome

Also Known As: Exosurf Neonatal; colfosceril; 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, hydroxide, inner salt, 4-oxide, (R)-, mixt. with formaldehyde polymer with oxirane and 4-(1,1,3,3-tetramethylbutyl)phenol, and 1-hexadecanol

Networked: 51 relevant articles (9 outcomes, 13 trials/studies) for this Drug

Key Diseases for which Exosurf is Relevant

  1. Newborn Respiratory Distress Syndrome : 2 outcomes 2 studies in 9 results
  2. Bronchopulmonary Dysplasia : 2 outcomes 2 studies in 7 results
  3. Pneumothorax : 2 outcomes 1 study in 4 results
  4. Lung Injury : 2 outcomes in 3 results
  5. Body Weight (Weight, Body) : 1 outcome 1 study in 6 results
Show All >>

Drugs Related to Exosurf

  1. beractant (Survanta)
  2. Surface-Active Agents (Surfactants)
  3. Carbon Monoxide
  4. Oxygen
  5. Exosurf (Exosurf Neonatal)
  6. 1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)
  7. calfactant
  8. Staphylococcal Protein A (A, Protein)
  9. poractant alfa (Curosurf)
  10. tyloxapol
Show All >>

Therapies Related to Exosurf

  1. Artificial Respiration (Mechanical Ventilation)
  2. Neonatal Intensive Care
  3. Mechanical Ventilators (Ventilator)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.